about
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agentsComputational strategy for quantifying human pesticide exposure based upon a saliva measurementAlternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MSInfluence of sampling on the determination of warfarin and warfarin alcohols in oral fluidNon-invasive saliva human biomonitoring: development of an in vitro platformEffect of probenecid on the distribution and elimination of ciprofloxacin in humans.The diagnostic applications of saliva--a review.Review of UCN-01 development: a lesson in the importance of clinical pharmacology.The use of oral fluid for therapeutic drug management: clinical and forensic toxicology.Saliva as a matrix for human biomonitoring in occupational and environmental medicine.Predicting Transport of 3,5,6-Trichloro-2-Pyridinol Into Saliva Using a Combination Experimental and Computational Approach.Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.A high performance liquid chromatographic assay of mefloquine in saliva after a single oral dose in healthy adult Africans.Comparison of drug concentrations between whole blood and oral fluid.Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology.Comparison of Cocaine/Crack Biomarkers Concentrations in Oral Fluid, Urine and Plasma Simultaneously Collected From Drug Users.Oral fluid testing for illicit substance use in preanaesthetic care.Relationships between nicotine and cotinine concentrations in maternal milk and saliva.Correlation between oral fluid and plasma oxytetracycline concentrations after intramuscular administration in pigs.Tacrolimus Concentration in Saliva of Kidney Transplant Recipients: Factors Influencing the Relationship with Whole Blood Concentrations.Chemical analysis in saliva and the search for salivary biomarkers - a tutorial review.Fetal exposure to tobacco: nicotine and cotinine concentration in amniotic fluid and maternal saliva.
P2860
Q26827380-E621FD3F-2AA8-4456-AB7D-25AEE92067E5Q26999435-B1C07969-54BD-40A9-87B2-1ECA67825BEDQ28083408-500F9C55-6419-4618-876D-0FEC1F73A825Q28542544-C40BB807-D715-48B2-AE00-C6104A401E93Q28950612-FC666EE8-DE70-4A25-888D-48EC971D9E3AQ34720221-A7B2DFFA-297A-48AA-AA8C-7DCF80671F4EQ34720733-623444B0-AF5B-4BAA-997D-A903177927F1Q36075195-95A92FAF-8873-40FE-A84F-D3AF7F5207DCQ36748921-D1DA2E42-370C-48F3-A84F-C241770A8977Q38195218-8BFF3EDB-D2CE-4D08-8B1D-FC00D056F281Q38731361-60FD4442-00D3-493A-A8E4-0DE86666987EQ39780456-ACFCFA63-4120-4AFE-AF45-C3BE542D0574Q41839958-C8B80B1E-FB29-4703-8462-8F2CDAECFD96Q43463638-A6023E6B-24DB-4461-868A-6115D78A5A9FQ47580223-18F47EEC-71C9-411B-B5C6-E9AFBE533222Q47593473-DF6F93CA-D7B6-44AC-8099-AE48D1BE6260Q48177406-4935B361-C2FE-492D-959B-B9A189F94B3DQ48197594-FA48024E-D5F2-4092-91EC-76241E0854CDQ48214637-8ABDFF04-CE57-4597-A22F-B5283F887E80Q48250195-FAFF68EC-8521-49EB-ADA9-F1CBCD2D30F4Q49922496-818BDCE2-4AE3-4BC8-8ECE-275BCB506E7DQ52854701-C940D511-C881-4748-8F06-2F03A86E1A72
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Factors influencing the saliva/plasma ratio of drugs.
@en
type
label
Factors influencing the saliva/plasma ratio of drugs.
@en
prefLabel
Factors influencing the saliva/plasma ratio of drugs.
@en
P2860
P1476
Factors influencing the saliva/plasma ratio of drugs.
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.1993.TB18347.X
P407
P577
1993-09-01T00:00:00Z